Anxiety and depression in small fiber neuropathy
- PMID: 36168866
- PMCID: PMC10091948
- DOI: 10.1111/jns.12514
Anxiety and depression in small fiber neuropathy
Abstract
Psychiatric comorbidity is common in patients with chronic pain. In peripheral neuropathic pain, particularly anxiety and mood disorders are frequently present and associated with a high level of catastrophizing. Small fiber neuropathy (SFN) is a peripheral neuropathy dominated by pain. This study aimed to investigate the prevalence of and factors associated with anxiety and depressive symptoms in SFN. All consecutive patients diagnosed with SFN at Maastricht University Medical Center+, between September 2016 and October 2021, were included (n = 1310). Data on demographics, medical history, diagnostic tests, and questionnaires about pain, SFN-specific symptoms, and mental health were collected once. The Hospital Anxiety and Depression Scale (HADS) was used to measure anxiety and depression and the Pain Catastrophizing Scale (PCS) to measure the degree of catastrophizing. One-third of the patients had an abnormal HADS score (≥11) on the subscales anxiety and/or depression (26.5% anxiety and 23.0% depression) indicating clinical relevance. Regression analysis showed that higher pain intensity, catastrophizing, and more SFN-related complaints were significantly associated with an abnormal HADS-score. In conclusion, the prevalence of reported anxiety or depressive symptoms in SFN is 36.3%. A multidisciplinary approach, not only focusing on pain relief, is therefore essential for the treatment of SFN.
Keywords: anxiety; association; depression; neuropathic pain; small fiber neuropathy.
© 2022 The Authors. Journal of the Peripheral Nervous System published by Wiley Periodicals LLC on behalf of Peripheral Nerve Society.
Conflict of interest statement
Dr. Damci, Dr. Schruers, and Dr. Leue declared no conflicts of interest. Dr. Faber reports grants from European Union's Horizon 2020 research and innovation programme Marie Sklodowska‐Curie grant for PAIN‐Net, Molecule‐to‐man pain network (grant no. 721841), grants from Grifols and Lamepro for a trial on IVIg in small fiber neuropathy, grants from Prinses Beatrix Spierfonds, Steering committees/advisory board for studies in small fiber neuropathy of Biogen/Convergence, Vertex, Lilly and OliPass, outside the submitted work. Dr. Hoeijmakers reports a grant from the Prinses Beatrix Spierfonds (W.OK17‐09). This work is generated within the European Reference Network for Neuromuscular Diseases.
Figures




References
-
- Castro M, Kraychete D, Daltro C, Lopes J, Menezes R, Oliveira I. Comorbid anxiety and depression disorders in patients with chronic pain. Arq Neuropsiquiatr. 2009;67:982‐985. - PubMed
-
- Radat F, Margot‐Duclot A, Attal N. Psychiatric co‐morbidities in patients with chronic peripheral neuropathic pain: a multicentre cohort study. Eur J Pain. 2013;17:1547‐1557. - PubMed
-
- Gureje O, Von Korff M, Kola L, et al. The relation between multiple pains and mental disorders: results from the world mental health surveys. Pain. 2008;135:82‐91. - PubMed
-
- Hooten WM. Chronic pain and mental health disorders: shared neural mechanisms, epidemiology, and treatment. Mayo Clin Proc. 2016;91:955‐970. - PubMed
-
- McWilliams LA, Cox BJ, Enns MW. Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain. 2003;106:127‐133. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous